Эпидемиология, патогенез и лечение кандидоза мочеполовых органов у женщин

Abstract

The objective: to review and analyze thematic publications on the study of epidemiology, pathogenesis of urogenital candidiasis in women. To increase the effectiveness of complex therapy of urogenital candidiasis in women with the use of anti-mycotic drugs of general and local action. Materials and methods. A clinical and laboratory examination of 23 women with urogenital candidiasis aged 21 to 45 years was conducted. Anamnestic data were studied and laboratory research methods were performed. Clinical diagnosis was based on identifying the totality of signs of the disease, which included recurrent pain in the area the appendages, menstrual dysfunction, vaginal discharge, periodic exacerbations of the disease. Results. Patients diagnosed with urogenital candidiasis and candidates are subject to mandatory therapy as potential sources of infection and autoinfection of the urogenital organs. It is necessary to treat sexual partners in a timely manner. An important medical problem is the improvement of treatment methods. It is necessary to pay special attention to urogenital candidal infection in view of the development of severe complications and the effect on the reproductive function of women. Conclusions. Comprehensive treatment of candidal infections of the urogenital tract in women using systemic antifungal drugs (Futsis, Eszol) and local drugs (Сlofan suppositories) is effective, does not cause side effects, and can be widely used by practitioners in practical health care, which will help reduce the number of relapses and more quickly recovery of patients. Key words: urogenital candidiasis, women, etiopathogenesis, clinic, treatment.